Sökresultat

Heart attack and stroke are common complications of diabetes, as the body's ability to repair and form vessels is impaired. Researchers at Lund University have developed a new substance with the capacity to stimulate vascular repair response and the formation of vessels. In diabetes, the body's ability to repair vascular damage caused by the disease is impaired, which can lead to complications suc

https://www.ludc.lu.se/article/new-peptide-may-reduce-risk-diabetes-complications - 2025-12-07

Precision medicine seeks to reduce errors and improve accuracy in medical and health recommendations, but better evidence is needed to fulfil its potential. An international consortium led by Paul Franks at Lund University presents new guidelines that may increase the clinical relevance of precision medicine research. An international consensus report on precision medicine that was published in Na

https://www.ludc.lu.se/article/new-guidelines-aim-increase-accuracy-precision-medicine-research - 2025-12-07

During his more than 50-year career, diabetes researcher Åke Lernmark has made several significant discoveries that have increased knowledge about type 1 diabetes. His research contributes to creating conditions for a national screening programme in Sweden. In Sweden, around 1,000 children and an equal number of adults develop type 1 diabetes each year. The disease has major consequences for the f

https://www.ludc.lu.se/article/scientist-who-paving-way-screening-type-1-diabetes - 2025-12-07

People with type 2 diabetes have a higher risk of developing cardiovascular disease and dying prematurely due to atherosclerosis. A research team at Lund University in Sweden has now identified molecular mechanisms that may explain the increased risk. Their discovery may lead to more accurate treatments for patients with atherosclerosis and type 2 diabetes in the future. People with type 2 diabete

https://www.ludc.lu.se/article/new-explanation-dangerous-atherosclerotic-plaques-type-2-diabetes - 2025-12-07

Obesity is a common cause of diabetes, heart disease and early death, but risk differs greatly from one person to the next. In work led by researchers at Lund University in Sweden as part of the Innovative Medicine Initiative project SOPHIA, a pioneering clinical risk prediction algorithm has been developed that splits obesity into 5 separate diagnostic profiles each with contrasting health conseq

https://www.ludc.lu.se/article/new-precision-medicine-approach-helps-detect-subgroups-people-obesity-high-risk-diabetes-and-heart - 2025-12-07

Diabetes researcher Joao Duarte specialices in studying what happens in the brain in diabetes. In his research, he is also investigating how diet changes can improve brain function in connection with diabetes. He will be awarded this year's Medeon stipend on the World Diabetes Day Skåne event in Malmö on November 14. "I hope that my research can contribute to an increased awareness of the importan

https://www.ludc.lu.se/article/praised-research-diabetes-and-dementia - 2025-12-07

In 2025, children within the TEDDY study will submit their final samples at research clinics in Sweden, Finland, Germany and the United States. The international study has provided a lot of new knowledge about type 1 diabetes and how the disease develops. Analysis of the samples will continue with the aim of preventing the disease. Sweden and Finland are the two top countries for incidence rates o

https://www.ludc.lu.se/article/new-knowledge-about-type-1-diabetes-large-scale-teddy-study-will-soon-be-completed - 2025-12-07

In type 2 diabetes, the body's ability to release insulin is impaired, which leads to high blood glucose levels. Research led from Lund University shows how the levels of a particular protein are elevated in the pancreas of people with type 2 diabetes. By knocking out the gene for the protein IGFBP7, the researchers discovered that insulin secretion was improved. Reduced insulin secretion leads to

https://www.ludc.lu.se/article/protein-affects-ability-secrete-insulin-type-2-diabetes - 2025-12-07

This year's recipient of the Leif C. Groop Award for Outstanding Diabetes Research maps out mechanisms in the adipose tissue, which has increased the understanding of why some people with obesity develop type 2 diabetes. Ingrid Wernstedt Asterholm at University of Gothenburg is spurred to find new answers when observations in the lab do not agree with the general view. Justification for awarding"I

https://www.ludc.lu.se/article/ingrid-wernstedt-asterholm-receives-leif-c-groop-award-research-adipose-tissue - 2025-12-07

Ingrid Wernstedt Asterholm received the Leif C. Groop Award for Outstanding Diabetes Research at the annual LUDC Diabetes Research Day. "This award allows me to rest in the feeling that all the work I have done is good enough, at least for a short while,” said the recipient. Ingrid Wernstedt Asterholm at Sahlgrenska Academy at University of Gothenburg is this year’s recipient of the Leif C. Groop

https://www.ludc.lu.se/article/diabetes-event-highlighted-findings-may-lead-new-treatments - 2025-12-07

New research at Lund University shows that the biological parents’ genes affect the child's insulin function and capacity to regulate blood sugar levels and blood lipids in different ways. Such knowledge may be used to develop preventive treatments that reduce the child's risk of developing type 2 diabetes and cardiovascular disease. Previous research by diabetes researcher Rashmi Prasad has shown

https://www.ludc.lu.se/article/new-study-parents-metabolic-traits-can-affect-childs-health-over-time - 2025-12-07

The results of an observational study from Lund University in Sweden are clear: up to the age of two, a more fibre-rich diet seems to reduce the risk of coeliac disease. A particularly clear link was seen when children had eaten fibre-rich foods before the age of one. “This is the first time the risk of coeliac disease has been studied based on fibre in children’s diets. But a clinical trial is al

https://www.ludc.lu.se/article/new-research-track-higher-amounts-dietary-fibre-age-two-can-reduce-later-risk-coeliac-disease - 2025-12-07

Type 2 diabetes is a chronic disease that usually requires lifelong treatment. A central goal for many diabetes researchers is to develop new cell therapies that can cure the disease. The Bo and Kerstin Hjelt Diabetes Foundation provides support to two diabetes researchers at Lund University Diabetes Centre who contribute with new knowledge to this research field. Type 1 diabetes is a condition wh

https://www.ludc.lu.se/article/hjelt-diabetes-foundation-supports-research-can-pave-way-new-cell-therapies - 2025-12-07

International researchers who study islets of Langerhans met for a conference in Malmö in June. Studies of insulin-producing cells help us understand disease mechanisms in diabetes. Lund University Diabetes Centre and the strategic research area EXODIAB hosted the event. Lund University Diabetes Centre (LUDC) and the strategic research are EXODIAB (Excellence of Diabetes Research in Sweden) hosted

https://www.ludc.lu.se/article/international-islet-cell-researchers-met-conference-malmo - 2025-12-07

Congratulations to Charlotte Ling who, together with Katarina Fagher and Alice Maguolo, has been awarded a grant of five million Danish kroner by the Novo Nordisk Foundation. The funding will support clinical research in precision medicine, focusing on epigenetic analysis of blood samples from 13,000 individuals. Charlotte Ling, a professor in diabetes research with a particular focus on epigeneti

https://www.ludc.lu.se/article/charlotte-ling-receives-major-grant-clinical-diabetes-research - 2025-12-07

An international research team led from Lund University, has identified epigenetic biomarkers that can predict which people with type 2 diabetes are at risk of cardiovascular disease. The study is now published in Cell Reports Medicine. People with type 2 diabetes are up to four times more likely to have heart attacks, strokes, anginas and other coronary heart diseases than healthy people. Therefo

https://www.ludc.lu.se/article/biomarkers-reveal-risk-cardiovascular-disease-type-2-diabetes - 2025-12-07

Inflammation researcher Ben King studies the function of two different proteins in connection with diabetes. In the future, such knowledge may be important for the development of new treatments for people with diabetes. Ben King is this year’s recipient of the Medeon Award for his innovative research. “I was very surprised and feel very honored to receive the award. In my role, I do a lot of exper

https://www.ludc.lu.se/article/award-protein-research-may-lead-new-treatments-diabetes - 2025-12-07

We would like to congratulate six researchers at Lund University Diabetes Centre, who have been awarded research grants within medicine and health by the Swedish Research Council (VR). The six researchers are affiliated with Excellence of Diabetes Research in Sweden (EXODIAB), which is a strategic research area within diabetes at Lund University.Helena Elding Larsson, professor of autoimmune disea

https://www.ludc.lu.se/article/six-ludc-researchers-receive-medicine-and-health-grants-vr - 2025-12-07

An international team of researchers has investigated whether oral insulin can prevent early signs of type 1 diabetes and clinical diagnosis in children with an increased risk of developing the disease. Although treatment with oral insulin could not prevent development of diabetes-related autoantibodies, oral insulin delayed the rate of disease progression in children who developed such autoantibo

https://www.ludc.lu.se/article/oral-insulin-delayed-onset-type-1-diabetes-some-children-increased-risk-disease - 2025-12-07

Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world. In a review in Science, Mark McCarthy, professor at the University of Oxford, UK, and Paul Franks, professor at Lund University, Sweden, examine the knowledge of the actual causes and the interplay between genetics and lifestyle factors. By studying how our genes express themselves in response

https://www.ludc.lu.se/article/review-type-2-diabetes-and-obesity-what-do-we-really-know - 2025-12-07